Historical Valuation
Ascentage Pharma Group International (AAPG) is now in the Undervalued zone, suggesting that its current forward PS ratio of 14.11 is considered Undervalued compared with the five-year average of -27.84. The fair price of Ascentage Pharma Group International (AAPG) is between 40.20 to 68.17 according to relative valuation methord. Compared to the current price of 28.32 USD , Ascentage Pharma Group International is Undervalued By 29.56%.
Relative Value
Fair Zone
40.20-68.17
Current Price：28.32
29.56%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Ascentage Pharma Group International (AAPG) has a current Price-to-Book (P/B) ratio of 95.17. Compared to its 3-year average P/B ratio of 138.46 , the current P/B ratio is approximately -31.26% higher. Relative to its 5-year average P/B ratio of 138.46, the current P/B ratio is about -31.26% higher. Ascentage Pharma Group International (AAPG) has a Forward Free Cash Flow (FCF) yield of approximately -1.29%. Compared to its 3-year average FCF yield of -1.60%, the current FCF yield is approximately -19.50% lower. Relative to its 5-year average FCF yield of -1.60% , the current FCF yield is about -19.50% lower.
Competitors Valuation Multiple
AI Analysis
The average P/S ratio for AAPG competitors is 36.26, providing a benchmark for relative valuation. Ascentage Pharma Group International Corp (AAPG.O) exhibits a P/S ratio of 14.11, which is -61.09% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of AAPG increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of AAPG in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is AAPG currently overvalued or undervalued?
Ascentage Pharma Group International (AAPG) is now in the Undervalued zone, suggesting that its current forward PS ratio of 14.11 is considered Undervalued compared with the five-year average of -27.84. The fair price of Ascentage Pharma Group International (AAPG) is between 40.20 to 68.17 according to relative valuation methord. Compared to the current price of 28.32 USD , Ascentage Pharma Group International is Undervalued By 29.56% .
What is Ascentage Pharma Group International (AAPG) fair value?
AAPG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Ascentage Pharma Group International (AAPG) is between 40.20 to 68.17 according to relative valuation methord.
How does AAPG's valuation metrics compare to the industry average?
The average P/S ratio for AAPG's competitors is 36.26, providing a benchmark for relative valuation. Ascentage Pharma Group International Corp (AAPG) exhibits a P/S ratio of 14.11, which is -61.09% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Ascentage Pharma Group International (AAPG) as of Jan 15 2026?
As of Jan 15 2026, Ascentage Pharma Group International (AAPG) has a P/B ratio of 95.17. This indicates that the market values AAPG at 95.17 times its book value.
What is the current FCF Yield for Ascentage Pharma Group International (AAPG) as of Jan 15 2026?
As of Jan 15 2026, Ascentage Pharma Group International (AAPG) has a FCF Yield of -1.29%. This means that for every dollar of Ascentage Pharma Group International’s market capitalization, the company generates -1.29 cents in free cash flow.
What is the current Forward P/E ratio for Ascentage Pharma Group International (AAPG) as of Jan 15 2026?
As of Jan 15 2026, Ascentage Pharma Group International (AAPG) has a Forward P/E ratio of -28.16. This means the market is willing to pay $-28.16 for every dollar of Ascentage Pharma Group International’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Ascentage Pharma Group International (AAPG) as of Jan 15 2026?
As of Jan 15 2026, Ascentage Pharma Group International (AAPG) has a Forward P/S ratio of 14.11. This means the market is valuing AAPG at $14.11 for every dollar of expected revenue over the next 12 months.